Primary Site >> Colorectal Cancer
Gene >> ERCC5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Frameshift mutations at mononucleotide repeats in RAD50 recombinational DNA repair gene in colorectal cancers with microsatellite instability. PMID: 11429044 |
Ref: Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. PMID: 12865926 |
Ref: DNA repair polymorphisms and risk of colorectal adenomatous or hyperplastic polyps. PMID: 16284370 |
Ref: Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. PMID: 16609022 |
Ref: Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine. PMID: 18204222 |
Ref: Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers. PMID: 18187810 |
Ref: Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. PMID: 19029193 Ref: ERCC5 promoter polymorphisms at -763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer. PMID: 19458483 Ref: Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array. PMID: 19536092 |
Ref: Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. PMID: 21561390 Ref: Development of quantitative DNA cleavage assay for XPG endonuclease activity using endogenous nuclear proteins in human cell lines. PMID: 21874251 |
Ref: The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. PMID: 21559836 Ref: DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy. PMID: 22213216 |
Ref: MTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland. PMID: 23626689 |
Ref: Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk. PMID: 24607854 Ref: Association study between XPG Asp1104His polymorphism and colorectal cancer risk in a Chinese population. PMID: 25332048 Ref: XPG Asp1104His polymorphism and gastrointestinal cancers risk: a meta-analysis. PMID: 25550928 |
Ref: Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients. PMID: 25355595 Ref: Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population. PMID: 25391773 Ref: An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population. PMID: 25835182 Ref: Genetic Association between ERCC5 rs17655 Polymorphism and Colorectal Cancer Risk: Evidence Based on a Meta-analysis. PMID: 26225711 |
Ref: XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer. PMID: 26887052 Ref: Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy. PMID: 27175691 Ref: XPG Gene Polymorphisms Contribute to Colorectal Cancer Susceptibility: A Two-Stage Case-Control Study. PMID: 27698911 |
Ref: The Association of Low-Penetrance Variants in DNA Repair Genes with Colorectal Cancer: A Systematic Review and Meta-Analysis. PMID: 28749454 |
Ref: The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis. PMID: 29568775 Ref: Nucleotide Excision Repair Factor XPC Ameliorates Prognosis by Increasing the Susceptibility of Human Colorectal Cancer to Chemotherapy and Ionizing Radiation. PMID: 30109214 |